Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Suzhou Novoprotein Scientific Co's average Total Assets Growth Rate was -10.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 48.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 72.90% per year.
During the past 8 years, Suzhou Novoprotein Scientific Co's highest 3-Year average Total Assets Growth Rate was 150.70%. The lowest was 48.90%. And the median was 107.50%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Suzhou Novoprotein Scientific Co's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Suzhou Novoprotein Scientific Co Total Assets Related Terms
Suzhou Novoprotein Scientific Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Novoprotein Scientific Co Total Assets Chart
Suzhou Novoprotein Scientific Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Total Assets of ¥2,145.9 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Suzhou Novoprotein Scientific Co and its competitors.
Is Suzhou Novoprotein Scientific Co's Total Assets too high?
Suzhou Novoprotein Scientific Co's current Total Assets is ¥2,145.9 Mil. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Total Assets compare to VRTX and REGN?
Suzhou Novoprotein Scientific Co's Total Assets of ¥2,145.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Suzhou Novoprotein Scientific Co and its competitors. Suzhou Novoprotein Scientific Co's current Total Assets is ¥2,145.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.76 — trading 7.9% below its estimated fair value. The current Total Assets is ¥2,145.9 Mil. Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Total Assets is ¥2,145.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued.
The current stock price of ¥34.76 is trading 7.9% below its estimated GF Value™ of ¥37.73.
GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.
Key valuation signals for SHSE:688137:
Total Assets: ¥2,145.9 Mil
GF Value™: ¥37.73 vs. price of ¥34.76 (7.9% below fair value)
No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzhou Novoprotein Scientific Co Business Description
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score
Get the complete analysis for SHSE:688137
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688137 has been successfully added to your 
